Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Nuvation Bio Inc. (NUVB)

Structure Therapeutics Inc. Sponsored ADR and Nuvation Bio Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Nuvation Bio Inc. are of similar size ($1.7B and $1.6B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −88.2%) and the lower return on invested capital (−1,371.8% vs 0.00%). Across the 14 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 8 and Nuvation Bio Inc. on 6.

Valuation

Metric GPCR NUVB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.13 9.71
P/B 1.12 6.11 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 6.71 9.21
Earnings yield (14.35%) (9.76%) (33.15%)
Free cash flow yield (14.75%) (7.79%) (25.50%)

Profitability

Metric GPCR NUVB Biotechnology median
Gross margin 0.00% 88.18% 65.16%
Operating margin 0.00% (81.00%) 0.00%
Net margin 0.00% (88.19%) 0.00%
Free cash flow margin 0.00% (71.17%) 0.00%
Return on equity (20.21%) (47.81%) (56.36%)
Return on assets (19.17%) (21.53%) (48.04%)
Return on invested capital (1,371.78%) 0.00% 0.00%

Growth

Metric GPCR NUVB Biotechnology median
Revenue growth (TTM) — 1,083.56% 6.02%
EPS growth (last fiscal year) (2.47%) 71.56% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR NUVB Biotechnology median
Debt to equity 0.00 0.98 0.00
Current ratio 20.75 8.37 4.72
Net debt to EBITDA 8.27 2.26 0.96

Dividend

Metric GPCR NUVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GPCR NUVB Biotechnology median
Market cap 1.58b 1.67b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack